NCT00919100

Brief Summary

A vibrating cold pack placed proximal to the site of venipuncture will decrease the pain of cannulation when compared to vapocoolant spray.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Apr 2008

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 12, 2009

Completed
9.3 years until next milestone

Results Posted

Study results publicly available

September 18, 2018

Completed
Last Updated

November 21, 2018

Status Verified

November 1, 2018

Enrollment Period

4 months

First QC Date

June 11, 2009

Results QC Date

April 29, 2018

Last Update Submit

November 19, 2018

Conditions

Keywords

pediatricvenipuncturepainvibrationvapocoolant

Outcome Measures

Primary Outcomes (1)

  • Faces Pain Scale-Revised (FPS-R)

    Self-report measure of pain via 6 faces ranging from neutral to increasing pain expression. The scoring for the scale ranges from 0-10 with lower scores representing lower pain and higher scores representing higher pain. The FPS-R was conducted several minutes following venipuncture. This time was not tracked, but it was typically between 2-5 minutes following completion of the venipuncture.

    5 minute

Secondary Outcomes (2)

  • OSBD-R Observational Pain/Distress Scale

    5 minute

  • Number of Participants With Venipuncture Success in One Attempt

    5 minutes

Study Arms (2)

Standard Care

OTHER

venipuncture with vapocoolant spray offered

Other: vapocoolant

Buzzy

EXPERIMENTAL

Vibrating device with cold pack held to arm with tourniquet proximal to venipuncture site, optional distraction cards.

Device: Buzzy

Interventions

BuzzyDEVICE

"Buzzy" is a vibrating cold pack attached with Velcro strap or tourniquet 5-10cm proximal to the site of venipuncture. The vibration is activated and the device remains in place throughout the procedure. The distraction cards are offered to the parents to show the children, with questions on the back and pictures on the front.

Also known as: BuzzyR
Buzzy

venipuncture with vapocoolant spray offered

Also known as: PainEase
Standard Care

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients requiring venipuncture in a pediatric emergency department
  • Informed consent
  • Patient assent

You may not qualify if:

  • Patients with sickle cell or other sensitivity to cold
  • Nerve damage in the area
  • Abrasion or break in skin where device would be placed
  • Critically ill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Healthcare of Atlanta, Scottish Rite

Atlanta, Georgia, 30342, United States

Location

Related Publications (1)

  • Baxter AL, Cohen LL, McElvery HL, Lawson ML, von Baeyer CL. An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department. Pediatr Emerg Care. 2011 Dec;27(12):1151-6. doi: 10.1097/PEC.0b013e318237ace4.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Amy Baxter
Organization
MMJ Labs

Study Officials

  • Amy L Baxter, MD

    Children's Healthcare of Atlanta

    PRINCIPAL INVESTIGATOR
  • Lindsey L Cohen, PhD

    Georgia State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 11, 2009

First Posted

June 12, 2009

Study Start

April 1, 2008

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

November 21, 2018

Results First Posted

September 18, 2018

Record last verified: 2018-11

Locations